| Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline AO Surov, AP Voronin, AN Manin, NG Manin, LG Kuzmina, AV Churakov, ... Molecular pharmaceutics 11 (10), 3707-3715, 2014 | 97 | 2014 |
| Pharmaceutical salts of ciprofloxacin with dicarboxylic acids AO Surov, AN Manin, AP Voronin, KV Drozd, AA Simagina, AV Churakov, ... European Journal of Pharmaceutical Sciences 77, 112-121, 2015 | 75 | 2015 |
| γ-Cyclodextrin-metal organic frameworks as efficient microcontainers for encapsulation of leflunomide and acceleration of its transformation into teriflunomide I Kritskiy, T Volkova, A Surov, I Terekhova Carbohydrate polymers 216, 224-230, 2019 | 67 | 2019 |
| Crystallization and polymorphism of felodipine AO Surov, KA Solanko, AD Bond, GL Perlovich, A Bauer-Brandl Crystal Growth & Design 12 (8), 4022-4030, 2012 | 64 | 2012 |
| Thermodynamic and structural aspects of some fenamate molecular crystals AO Surov, IV Terekhova, A Bauer-Brandl, GL Perlovich Crystal Growth and Design 9 (7), 3265-3272, 2009 | 63 | 2009 |
| Cocrystals of the antiandrogenic drug bicalutamide: Screening, crystal structures, formation thermodynamics and lattice energies AO Surov, KA Solanko, AD Bond, A Bauer-Brandl, GL Perlovich CrystEngComm 18 (25), 4818-4829, 2016 | 48 | 2016 |
| Weak interactions cause packing polymorphism in pharmaceutical two-component crystals. The case study of the salicylamide cocrystal AO Surov, AN Manin, AP Voronin, AV Churakov, GL Perlovich, MV Vener Crystal Growth & Design 17 (3), 1425-1437, 2017 | 47 | 2017 |
| New solid forms of the antiviral drug arbidol: Crystal structures, thermodynamic stability, and solubility AO Surov, AN Manin, AV Churakov, GL Perlovich Molecular Pharmaceutics 12 (11), 4154-4165, 2015 | 40 | 2015 |
| Cocrystals of fluconazole with aromatic carboxylic acids: Competition between anhydrous and hydrated solid forms AO Surov, AP Voronin, NA Vasilev, AV Churakov, GL Perlovich Crystal Growth & Design 20 (2), 1218-1228, 2019 | 39 | 2019 |
| Thermodynamic properties of flufenamic and niflumic acids—Specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and … GL Perlovich, AO Surov, A Bauer-Brandl Journal of pharmaceutical and biomedical analysis 45 (4), 679-687, 2007 | 39 | 2007 |
| Cocrystal formation, crystal structure, solubility and permeability studies for novel 1, 2, 4-thiadiazole derivative as a potent neuroprotector AO Surov, TV Volkova, AV Churakov, AN Proshin, IV Terekhova, ... European Journal of Pharmaceutical Sciences 109, 31-39, 2017 | 38 | 2017 |
| Specific features of supramolecular organisation and hydrogen bonding in proline cocrystals: A case study of fenamates and diclofenac AO Surov, AP Voronin, MV Vener, AV Churakov, GL Perlovich CrystEngComm 20 (43), 6970-6981, 2018 | 37 | 2018 |
| Fenamate cocrystals with 4, 4′-bipyridine: structural and thermodynamic aspects AO Surov, AA Simagina, NG Manin, LG Kuzmina, AV Churakov, ... Crystal Growth & Design 15 (1), 228-238, 2015 | 37 | 2015 |
| Energetic aspects of diclofenac acid in crystal modifications and in solutions—mechanism of solvation, partitioning and distribution GL Perlovich, AO Surov, LK Hansen, A Bauer-Brandl Journal of pharmaceutical sciences 96 (5), 1031-1042, 2007 | 37 | 2007 |
| Novel cocrystals of itraconazole: Insights from phase diagrams, formation thermodynamics and solubility NA Vasilev, AO Surov, AP Voronin, KV Drozd, GL Perlovich International Journal of Pharmaceutics 599, 120441, 2021 | 36 | 2021 |
| Solid forms of ciprofloxacin salicylate: polymorphism, formation pathways, and thermodynamic stability AO Surov, NA Vasilev, AV Churakov, J Stroh, F Emmerling, GL Perlovich Crystal Growth & Design 19 (5), 2979-2990, 2019 | 34 | 2019 |
| Thermodynamic and structural study of tolfenamic acid polymorphs AO Surov, P Szterner, W Zielenkiewicz, GL Perlovich Journal of pharmaceutical and biomedical analysis 50 (5), 831-840, 2009 | 33 | 2009 |
| Three polymorphic forms of ciprofloxacin maleate: formation pathways, crystal structures, calculations, and thermodynamic stability aspects AO Surov, AV Churakov, GL Perlovich Crystal Growth & Design 16 (11), 6556-6567, 2016 | 30 | 2016 |
| Pharmaceutical salts of fenbendazole with organic counterions: structural analysis and solubility performance AO Surov, NA Vasilev, MV Vener, OD Parashchuk, AV Churakov, ... Crystal Growth & Design 21 (8), 4516-4530, 2021 | 28 | 2021 |
| Diversity of crystal structures and physicochemical properties of ciprofloxacin and norfloxacin salts with fumaric acid AO Surov, AP Voronin, KV Drozd, AV Churakov, P Roussel, GL Perlovich CrystEngComm 20 (6), 755-767, 2018 | 28 | 2018 |
